Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Medidata Solutions, Inc. (MDSO)
|
Add to portfolio |
|
|
|
| Price: |
$92.22
| | Metrics |
| OS: |
62.5
|
M
| |
7
|
% ROE
|
| Market cap: |
$5.76
|
B
| |
10
|
% ROIC
|
|
Net cash:
|
$206
|
M
| |
$3.30
|
per share
|
|
EV:
|
$5.55
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$73.1
|
M
| |
75.9
|
x EV/EBITDA
|
|
EBIT
|
$32.1
|
M
| |
172.8
|
x EV/EBIT
|
| EPS |
$0.71
| |
129.1
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 635.7 | 544.2 | 458.5 | 392.5 | 335.1 | 276.8 | 218.3 | 184.5 |
| Revenue growth | 16.8% | 18.7% | 16.8% | 17.1% | 21.0% | 26.8% | 18.4% | 10.8% |
| Cost of goods sold | 159.2 | 126.8 | 112.6 | 89.8 | 182.9 | 69.9 | 62.7 | 52.8 |
| Gross profit | 476.5 | 417.4 | 345.9 | 302.7 | 152.1 | 206.9 | 155.7 | 131.6 |
| Gross margin | 75.0% | 76.7% | 75.4% | 77.1% | 45.4% | 74.7% | 71.3% | 71.4% |
| Sales and marketing | 151.9 | 124.1 | 105.9 | 103.2 | 83.4 | 66.3 | 47.7 | 36.1 |
| Research and development | 162.8 | 138.6 | 112.6 | 92.3 | 71.8 | 51.2 | 42.3 | 29.6 |
| General and administrative | 110.5 | 94.3 | 78.7 | 78.0 | 69.1 | 65.5 | 37.8 | 37.1 |
| EBITA | 57.3 | 69.6 | 50.0 | 29.9 | 20.7 | 24.7 | 29.7 | 30.4 |
| EBITA margin | 9.0% | 12.8% | 10.9% | 7.6% | 6.2% | 8.9% | 13.6% | 16.5% |
| Amortization of intangibles | 6.3 | 4.1 | 1.3 | 0.6 | 0.6 | 0.8 | 1.8 | 1.6 |
| EBIT | 51.0 | 65.5 | 48.7 | 29.2 | 20.1 | 23.9 | 27.9 | 28.9 |
| EBIT margin | 8.0% | 12.0% | 10.6% | 7.4% | 6.0% | 8.6% | 12.8% | 15.6% |
| Pre-tax income | 50.1 | 53.0 | 35.8 | 15.8 | 6.5 | 18.4 | 28.1 | 23.0 |
| Income taxes | -1.8 | 5.5 | 7.8 | 2.6 | 0.4 | 1.7 | 10.0 | -16.4 |
| Tax rate | | 10.3% | 21.7% | 16.5% | 6.5% | 9.4% | 35.8% | |
| Net income | 51.9 | 47.6 | 28.0 | 13.2 | 6.1 | 16.7 | 18.0 | 39.4 |
| Net margin | 8.2% | 8.7% | 6.1% | 3.4% | 1.8% | 6.0% | 8.3% | 21.4% |
| |
| Diluted EPS | $0.85 | $0.80 | $0.49 | $0.23 | $0.11 | $0.31 | $0.35 | $0.80 |
| Shares outstanding (diluted) | 61.2 | 59.8 | 57.2 | 56.5 | 55.2 | 54.1 | 50.9 | 49.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|